55102-99-3

Basic information

• Product Name: 1-Bromo-4-(4-fluorophenoxy)benzene
• Synonyms: 1-Bromo-4-(4-fluorophenoxy)benzene
• CAS NO: 55102-99-3
• Molecular Formula: C₁₂H₈BrFO
• Molecular Weight: 267.0937232
• Mol File: 55102-99-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 297.7°Cat760mmHg
• Flash Point: 162.2°C
• Appearance: /
• Density: 1.48g/cm³
• Vapor Pressure: 0.00235mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Room temperature.
• CAS DataBase Reference: 1-Bromo-4-(4-fluorophenoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-4-(4-fluorophenoxy)benzene(55102-99-3)
• EPA Substance Registry System: 1-Bromo-4-(4-fluorophenoxy)benzene(55102-99-3)

Safety Data

• Hazardous Substances Data: 55102-99-3(Hazardous Substances Data)

Usage

Description

1-Bromo-4-(4-fluorophenoxy)benzene is a brominated aromatic compound with the molecular formula C12H8BrFOP and a molecular weight of 289.09 g/mol. It features a fluorophenoxy group attached to the benzene ring, giving it unique chemical properties and potential applications in various industries.

Uses

Used in Pharmaceutical and Agrochemical Industries:
1-Bromo-4-(4-fluorophenoxy)benzene is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals for its ability to be incorporated into complex organic molecules, contributing to the development of new drugs and pesticides.
Used in Liquid Crystal and Electronic Material Production:
1-Bromo-4-(4-fluorophenoxy)benzene is utilized in the production of liquid crystals and electronic materials due to its chemical structure and properties that make it suitable for these high-tech applications.
Used in Industrial Processes:
1-Bromo-4-(4-fluorophenoxy)benzene's colorless to pale yellow liquid state and its high boiling point with a low melting point make it useful in a variety of industrial processes where specific physical and chemical characteristics are required.
Safety Note:
It is important to handle 1-Bromo-4-(4-fluorophenoxy)benzene with care, as it is hazardous if ingested or inhaled and can cause skin and eye irritation. Proper safety measures should be taken during its use and storage to minimize risks.

InChI:InChI=1/C12H8BrFO/c13-9-1-5-11(6-2-9)15-12-7-3-10(14)4-8-12/h1-8H

Upstream product

• 106-41-2 4-bromo-phenol 
• 1765-93-1 4-fluoroboronic acid 
• 371-41-5 4-Fluorophenol 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 589-87-7 1,4-bromoiodobenzene 
• 330-84-7 4-fluorophenoxybenzene 

Downstream Products

• 1127563-68-1 6-(4-(4-fluorophenoxy)phenyl)pyridine-2-carbonitrile N-oxide 
• 1367127-21-6 C₁₉H₁₄FNO₄ 
• 1367126-53-1 C₁₈H₁₄FNO₂ 
• 1367126-51-9 C₁₉H₁₄FNO₃ 
• 1367124-88-6 6-(4-(4-fluorophenoxy)phenyl)-4-((2-morpholinoethyl)amino)picolinamide 
• 1367126-66-6 C₂₄H₂₃FN₄O₂ 
• 1127563-71-6 6-(4-(4-fluorophenoxy)phenyl)-4-chloropyridine-2-carbonitrile 
• 1367127-23-8 C₂₀H₁₃FN₂O₃ 
• 1367127-25-0 C₁₉H₁₃FN₂O₂ 
• 1367127-27-2 C₂₆H₁₉FN₂O₄S 
• 1367127-30-7 C₂₈H₂₉FN₄O₃ 
• 1367127-32-9 C₂₈H₃₁FN₄O₄ 
• 1367127-34-1 C₂₉H₃₃FN₄O₄ 
• 1367127-56-7 C₂₀H₁₃FN₂O 

Relevant articles and documents

CYCLIC MOLECULES AS BRUTON'S TYROSINE KINASE INHIBITOR

The present invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, and the synthesis and usage thereof. Specifically, the present invention relates to compound by formula A, pharmaceutically acceptable salts, hydrates or solvates thereof, and the synthesis and usage thereof.

Platinum(II) cyclometallates featuring broad emission bands and their applications in color-tunable OLEDs and high color-rendering WOLEDs

Two phosphorescent platinum(ii) cyclometallated complexes with phenoxy groups (1 and 2) have been developed. The modified organic ligands derived by combining the phenoxy moiety and 2-phenylpyridine conferred them with a more flexible structure, leading to superior intermolecular interaction properties of the resulting Pt(ii) metallophosphors. Because of the excimer formation induced by Pt(ii) complexes 1 and 2, the emission color can be tuned over a wide range from cyan to orange by simply increasing the concentration of the Pt(ii) metallophosphors. Inspired by their broad emission band, color tunability and outstanding electroluminescence (EL) performance, these two Pt(ii) phosphors complemented with blue fluorescent emitter 4,4′-bis(9-ethyl-3-carbazovinylene)-1,1′-biphenyl (BCzVBi) were employed in manufacturing high color-rendering white organic light-emitting devices (WOLEDs). In such simple two-emitter systems, 1-based WOLEDs exhibited reasonable EL performance with an external quantum efficiency (ηext) of 11.7%, luminance efficiency (ηL) of 29.1 cd A-1, power efficiency (ηp) of 16.9 lm W-1 and color rendering index (CRI) of 77, whereas 2-based WOLEDs demonstrated an ηext of 10%, ηL of 21.7 cd A-1, ηp of 10.7 lm W-1 and CRI of 88.

PYRIDINE COMPOUNDS AND THE USES THEREOF

The invention relates to substituted pyridine compounds of Formula (I) and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein R1a, A1, A2, E, G, Z1, and Z2 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.